Dr Jean-Louis Klein
Scientific Director
GlaxoSmithKline
Research Interests
Drug development, Cancer, Inflammation, 3D cellular model, Human relevant model, Target validation
Pharmaceutical research strongly needs more human physiologically relevant models to predict effect of new molecules in patients. I am interested in all new models that are potentially predictive of human physiology.